Kamal Ramani Internal Medicine is categorized under Internal Medicine Doctors in New York City, NY and active since 2008.
Kamal Ramani Internal Medicine was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Kamal Ramani at the company’s single location by writing to 235 East 40th St Apartment 20d, New York City, New York NY 10016 or by phoning (212) 661-0570. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Kamal Ramani Internal Medicine |
Contact Person: | Kamal Ramani |
Address: | 235 East 40th St Apartment 20d, New York City, New York 10016 |
Phone Number: | (212) 661-0570 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Kamal Ramani Internal Medicine was started in 2008 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kamal Ramani for inquiries that concern Kamal Ramani Internal Medicine by calling the company number (212) 661-0570, as your correspondence is most welcome. Additionally, the physical location of the single location of Kamal Ramani Internal Medicine can be found at the coordinates as well as the street address 235 East 40th St Apartment 20d in New York City, New York 10016.
For its online presence, you may visit Kamal Ramani Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.